Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × durvalumab × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 CNS 1

Conditions

Carcinoma, Hepatocellular 26 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 14 Cholangiocarcinoma 13 Biliary Tract Neoplasms 13 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Liver Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma 4 Stomach Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Gallbladder Neoplasms 3 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Bile Duct Neoplasms 2 Advanced Biliary Tract Cancer 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Adenocarcinoma 2 Vaccinia 1 Unresectable Hepatocellular Carcinoma 1 SCLC, Limited Stage 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1

Interventions

Magnetic Resonance Spectroscopy 20 Temozolomide 14 Radiotherapy 9 Specimen Handling 7 Radiation 6 Blood Specimen Collection 6 Bevacizumab 4 trametinib 3 pembrolizumab 3 Surgical Procedures, Operative 3 Nivolumab 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 vorasidenib 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 fluciclovine F-18 2 dabrafenib 2 X-Rays 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Magnetic Resonance Imaging 2 Infusions, Intravenous 2 Genetic Testing 2 Everolimus 2 Etoposide 2 Elasticity Imaging Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03991832 2024-07-18

SOLID

University Health Network, Toronto

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡